Multiple Sclerosis Patients look forward to a day with no injections
Posted Nov 17 2009 10:20pm
Examiner.com - written by: Mike Szymanski July 23, 2009
German drug makers apply to approve MS pill
Imagine a day with no injections? Multiple Sclerosis suffers can look forward to such a day after the German-based company Merck KGaA asked European regulators to approve its pill for the debilitating nerve disease.
It's really a battle between companies. The German company is racing with Novartis AG to release the first oral medicine for MS. The company asked for European Medicine Agency approval of a pill, called cladribine, and the next step is to get U.S. approval.